These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15297165)

  • 21. Genomic integration of oncogenic HPV and gain of the human telomerase gene TERC at 3q26 are strongly associated events in the progression of uterine cervical dysplasia to invasive cancer.
    Hopman AH; Theelen W; Hommelberg PP; Kamps MA; Herrington CS; Morrison LE; Speel EJ; Smedts F; Ramaekers FC
    J Pathol; 2006 Dec; 210(4):412-9. PubMed ID: 17054308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-(4-hydroxyphenyl)retinamide activation of transforming growth factor-beta and induction of apoptosis in human breast cancer cells.
    Herbert BS; Sanders BG; Kline K
    Nutr Cancer; 1999; 34(2):121-32. PubMed ID: 10578478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of aberrant proliferation and induction of apoptosis in HER-2/neu oncogene transformed human mammary epithelial cells by N-(4-hydroxyphenyl)retinamide.
    Jinno H; Steiner MG; Mehta RG; Osborne MP; Telang NT
    Carcinogenesis; 1999 Feb; 20(2):229-36. PubMed ID: 10069458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral diindolylmethane (DIM): pilot evaluation of a nonsurgical treatment for cervical dysplasia.
    Del Priore G; Gudipudi DK; Montemarano N; Restivo AM; Malanowska-Stega J; Arslan AA
    Gynecol Oncol; 2010 Mar; 116(3):464-7. PubMed ID: 19939441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fluorescence in situ hybridization in cervical smears: detection of numerical aberrations of chromosomes 7, 3, and X and relationship to HPV infection.
    Mian C; Bancher D; Kohlberger P; Kainz C; Haitel A; Czerwenka K; Stani J; Breitenecker G; Wiener H
    Gynecol Oncol; 1999 Oct; 75(1):41-6. PubMed ID: 10502423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-steroidal anti-inflammatory agents to induce regression and prevent the progression of cervical intraepithelial neoplasia.
    Grabosch SM; Shariff OM; Helm CW
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD004121. PubMed ID: 29431861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemoprevention trials and surrogate end point biomarkers in the cervix.
    Mitchell MF; Hittelman WK; Lotan R; Nishioka K; Tortolero-Luna G; Richards-Kortum R; Wharton JT; Hong WK
    Cancer; 1995 Nov; 76(10 Suppl):1956-77. PubMed ID: 8634987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized study of hexaminolevulinate photodynamic therapy in patients with cervical intraepithelial neoplasia 1/2.
    Hillemanns P; Garcia F; Petry KU; Dvorak V; Sadovsky O; Iversen OE; Einstein MH
    Am J Obstet Gynecol; 2015 Apr; 212(4):465.e1-7. PubMed ID: 25467012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemoprevention of breast cancer with fenretinide (4-HPR): study of long-term visual and ophthalmologic tolerability.
    Mariani L; Formelli F; De Palo G; Manzari A; Camerini T; Campa T; Di Mauro MG; Crippa A; Delle Grottaglie M; Del Vecchio M; Marubini E; Costa A; Veronesi U
    Tumori; 1996; 82(5):444-9. PubMed ID: 9063520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heteromorphisms of C-bands in patients with precancerous and cancerous lesions of the cervix uteri.
    Murty VV; Mitra AB; Singh IP; Luthra UK
    Oncology; 1987; 44(3):164-8. PubMed ID: 3601318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparison and analysis of expression of c-myc and p16 in cervical carcinoma].
    Ruan YH; Wei WL; Zhang HX; Liang ZN; Liu BY; Chen Y
    Ai Zheng; 2003 Jun; 22(6):602-6. PubMed ID: 12948409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Results of a phase II double-blinded randomized clinical trial of difluoromethylornithine for cervical intraepithelial neoplasia grades 2 to 3.
    Vlastos AT; West LA; Atkinson EN; Boiko I; Malpica A; Hong WK; Follen M
    Clin Cancer Res; 2005 Jan; 11(1):390-6. PubMed ID: 15671570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical significance of numerical aberrations on chromosome 17 in uterine cervical and endometrial neoplasias.
    Kudo K; Sato S; Yokoyama Y; Fukushi Y; Maruyama H; Saito Y
    Eur J Gynaecol Oncol; 2000; 21(5):491-3. PubMed ID: 11198040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ZYC101a for treatment of high-grade cervical intraepithelial neoplasia: a randomized controlled trial.
    Garcia F; Petry KU; Muderspach L; Gold MA; Braly P; Crum CP; Magill M; Silverman M; Urban RG; Hedley ML; Beach KJ
    Obstet Gynecol; 2004 Feb; 103(2):317-26. PubMed ID: 14754702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ectopic chromosome around centrosome in metaphase cells as a marker of high-risk human papillomavirus-associated cervical intraepithelial neoplasias.
    Furuta R; Hirai Y; Katase K; Tate S; Kawaguchi T; Akiyama F; Kato Y; Kumada K; Iwasaka T; Yaegashi N; Kanazawa K; Yoshikawa H; Kitagawa T
    Int J Cancer; 2003 Aug; 106(2):167-71. PubMed ID: 12800190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fenretinide breast cancer prevention trial: drug and retinol plasma levels in relation to age and disease outcome.
    Formelli F; Camerini T; Cavadini E; Appierto V; Villani MG; Costa A; De Palo G; Di Mauro MG; Veronesi U
    Cancer Epidemiol Biomarkers Prev; 2003 Jan; 12(1):34-41. PubMed ID: 12540501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer risk factors for selecting cohorts for large-scale chemoprevention trials.
    Greenwald P
    J Cell Biochem Suppl; 1996; 25():29-36. PubMed ID: 9027595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of N-(4-hydroxyphenyl)retinamide on hTERT expression in the bronchial epithelium of cigarette smokers.
    Soria JC; Moon C; Wang L; Hittelman WN; Jang SJ; Sun SY; Lee JJ; Liu D; Kurie JM; Morice RC; Lee JS; Hong WK; Mao L
    J Natl Cancer Inst; 2001 Aug; 93(16):1257-63. PubMed ID: 11504771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topical treatment of CIN 2+ by cidofovir: results of a phase II, double-blind, prospective, placebo-controlled study.
    Van Pachterbeke C; Bucella D; Rozenberg S; Manigart Y; Gilles C; Larsimont D; Vanden Houte K; Reynders M; Snoeck R; Bossens M
    Gynecol Oncol; 2009 Oct; 115(1):69-74. PubMed ID: 19647859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Numerical aberrations of chromosome 1 in cervical intraepithelial neoplasia are strongly associated with infection with high-risk human papillomavirus types.
    Bulten J; Melchers WJ; Kooy-Smits MM; de Wilde PC; Poddighe PJ; Robben JC; Macville MV; Massuger LF; Bakkers JM; Hanselaar AG
    J Pathol; 2002 Nov; 198(3):300-9. PubMed ID: 12375262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.